{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:23:16Z","timestamp":1760188996444},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1989,5,1]],"date-time":"1989-05-01T00:00:00Z","timestamp":609984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["I.J.M.S."],"published-print":{"date-parts":[[1989,5]]},"DOI":"10.1007\/bf02943033","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T15:44:58Z","timestamp":1220802298000},"page":"97-101","source":"Crossref","is-referenced-by-count":3,"title":["Recent experience with intensive combination chemotherapy for treatment of childhood acute lymphoblastic leukaemia"],"prefix":"10.1007","volume":"158","author":[{"given":"E.","family":"Vandenberghe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Staines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Breatnach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"O\u2019Meara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02943033_CR1","first-page":"87","volume-title":"Treatment strategy for different risk groups in childhood acute lymphoblastic leukaemia: A report from the BFM study group","author":"G. Henze","year":"1981","unstructured":"Henze, G., Langermann, H. J., Ritter, J., Schellong, G., Riehm, H. Treatment strategy for different risk groups in childhood acute lymphoblastic leukaemia: A report from the BFM study group. In: Neth, Gallo, Graf, Mannweiler, Winkler (eds): \u201cModern Trends in Human Leukaemia\u201d, IV, Vol, 26, Berlin: Springer-Verlag, 1981, pp. 87\u201393."},{"key":"BF02943033_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM198609113151101","volume":"315","author":"L. A. Clavell","year":"1986","unstructured":"Clavell, L. A., Gelber, R. D., Cohen, H. J., Hitchcock-Bryan, S., Cassady, J. R., Tarbell, N. H., Blattner, S. R., Tantravahi, R., Leavitt, P., Sallan, S. E. Four agent induction and intensive acute lymphoblastic leukaemia. N. Eng. J. Med. 1986: 315, 657\u2013663.","journal-title":"N. Eng. J. Med."},{"key":"BF02943033_CR3","first-page":"1041","volume":"51","author":"D. R. Miller","year":"1983","unstructured":"Miller, D. R., Leiken, S., Albo, V., Sather, H., Karon, M., Hammond, D. Prognostic factors and therapy in acute lymphoblastic leukaemia of childhood: CCG-41. Cancer 1983: 51, 1041\u20131049.","journal-title":"CCG-41. Cancer"},{"key":"BF02943033_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2008-1026780","volume":"199","author":"M. Schrappe","year":"1987","unstructured":"Schrappe, M., Beck, J., Brandeis, W. E., Feickert, H. J., Gadner, H., Graf, N., Havers, W., Henze, G., Jobke, A., Korn-hubber, B., Kuhl, J., Lampert, F., Muller-Weinreich, S. T., Niethammer, D., Reiter, A., Rister, M., Ritter, J., Schellong, G., Tausch, W., Weinel, P., Reim, H. Die Behandlung derakuten lymphoblastischen Leukaemie im Kindes-und Jugendalter: ErgbnissedermultizentrischenTherapiestudie ALL-BFM 81. Klin. Padiat. 1987: 199, 133\u2013150.","journal-title":"Klin. Padiat."},{"key":"BF02943033_CR5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"J. M. Bennett","year":"1976","unstructured":"Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Gallon, D. A. G., Gralnick, H. R., Sultan, C. (FAB Co-operative Group). Proposals for the classification of the acute leukaemias. Br. J. Haematol. 1976: 33, 451\u2013458.","journal-title":"Br. J. Haematol."},{"key":"BF02943033_CR6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(85)92085-9","volume":"i","author":"L. C. Chan","year":"1985","unstructured":"Chan, L. C., Pegram, S. M., Greaves, M. F. Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemia. Lancet 1985: i, 475\u2013479.","journal-title":"Lancet"},{"key":"BF02943033_CR7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V54.6.1203.1203","volume":"54","author":"F. J. Bollum","year":"1979","unstructured":"Bollum, F. J. Terminal deoxynucleotidyl transferase as a haematopoietic cell marker: A review. Blood 1979: 54, 1203\u20131215.","journal-title":"A review. Blood"},{"key":"BF02943033_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R. Peto","year":"1977","unstructured":"Peto, R., Pike, M. C., Armitage, P., Breslow, N. G., Cox, D. R., Howard, S. V., Mantel, M., McPherson, K., Peto, J., Smith, P. G. Design and anlaysis of randomised clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br. J. Cancer 1977: 35, 1\u201339.","journal-title":"Br. J. Cancer"},{"key":"BF02943033_CR9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1981.tb07241.x","volume":"49","author":"F. Breatnach","year":"1981","unstructured":"Breatnach, F., Chessells, J. M., Greaves, M. F. The aplastic presentation of childhood leukaemia; a feature of common acute lymphoblastic leukaemia. Br. J. Haematol. 1981: 49, 387\u2013393.","journal-title":"Br. J. Haematol."},{"key":"BF02943033_CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpo.2950160304","volume":"16","author":"A. O\u2019Meara","year":"1988","unstructured":"O\u2019Meara. A., Daly, M., Hallinan, F. H. Increased antithrombin III concentration in children with acute lymphatic leukaemia receiving L-asparaginase therapy. Med. Pediatr. Oncol. 1988: 16, 169\u2013174.","journal-title":"Med. Pediatr. Oncol."},{"key":"BF02943033_CR11","first-page":"1100","volume":"135","author":"B. I. Asmar","year":"1980","unstructured":"Asmar, B. I., Maqbool, S., Dajani, A. S. Hematologic abnormalities after oral Trimethoprim-Sulphamethoxazole therapy in children, Am. J. Dis. Child. 1980. 135, 1100\u20131103.","journal-title":"Am. J. Dis. Child."},{"key":"BF02943033_CR12","first-page":"408","volume":"i","author":"The Medical Research Council UK ALL Trials","year":"1986","unstructured":"The Medical Research Council UK ALL Trials, 1972\u20131984. Report to the Council by the Working Party on Leukaemia in Childhood: Improvement in treatment for children with acute lymphoblastic leukaemia. Lancet 1986: i, 408\u2013411.","journal-title":"Lancet"},{"key":"BF02943033_CR13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(81)91216-2","volume":"ii","author":"A. Meadows","year":"1981","unstructured":"Meadows, A., Massari, D. J., Fergusson, J., Gordon, J., Littman, P., Moss, K. Declines in IQ scores and cognitive dysfunctions in children with acute lymphoblastic leukaemia treated with cranial radiation. Lancet 1981: ii, 1015\u20131018.","journal-title":"Lancet"},{"key":"BF02943033_CR14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(87)90004-3","volume":"ii","author":"J. A. Kirk","year":"1987","unstructured":"Kirk, J. A., Stevens, M. M., Menser, M. A., Tink, A., Raghupathy, P., Cowell, C. T., Bergin, M., Vines, R., Silink, M. Growth failure and growth hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1987: ii, 190\u2013193.","journal-title":"Lancet"},{"key":"BF02943033_CR15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood.V71.4.866.866","volume":"71","author":"M. Abromowitch","year":"1988","unstructured":"Abromowitch, M., Ocus, J., Puich, Fair-clough, D., Murphy, S. B., Rivera, G. K. Efficacy of high dose Methotrexate in childhood acute lymphocytic leukaemia: Analysis by contemporary risk classifications. Blood 1988: 71, 866\u2013869.","journal-title":"Blood"},{"key":"BF02943033_CR16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/1097-0142(19820915)50:6<1031::AID-CNCR2820500602>3.0.CO;2-7","volume":"50","author":"D. M. Komp","year":"1982","unstructured":"Komp, D. M., Fernandez, C. H., Falletta, J. M., Ragab, A. H., Humphrey, G. B., Pullen, J., Moon, T., Shustor, J. CNS prophylaxis in acute lymphoblastic leukaemia. Comparison of two methods. A Southwest Oncology Group Study. Cancer 1982: 50, 1031\u20131036.","journal-title":"Cancer"},{"key":"BF02943033_CR17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V60.4.948.948","volume":"60","author":"M. P. Sullivan","year":"1982","unstructured":"Sullivan, M. P., Chen, P. G., Huizdal, A. E., Steuber, C. P. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute, lymphatic leukaemia: A paediatric oncology group study. Blood 1982: 60, 948\u201395","journal-title":"Blood"},{"key":"BF02943033_CR18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/1097-0142(19880301)61:5<857::AID-CNCR2820610502>3.0.CO;2-S","volume":"61","author":"L. S. Lashford","year":"1988","unstructured":"Lashford, L. S., Davies, A. G., Richardson, R. B., Bourne, S. P., Bullimore, J. A., Eckert, H., Kemshead, J. T., Coakham, H. B. A pilot study of131I monoclonal antibodies in the therapy of leptomeningeal tumours. Cancer 1988: 61, 857\u2013868.","journal-title":"Cancer"},{"key":"BF02943033_CR19","first-page":"694","volume":"63","author":"R. L. Capizzi","year":"1984","unstructured":"Capizzi, R. L., Poole, M., Cooper, M. R., Richards, F., Stuart, J. J., Jackson, D. U., White, D. R., Spurr, C. L., Hopkins, J. O., Muss, H. B., Rudnick, S. A., Wells, R., Gabriel, D., Ross, D. Treatment of poor risk acute leukaemia with sequential high dose ARA-C and Asparaginase. Blood 1984: 63, 694\u2013700.","journal-title":"Blood"},{"key":"BF02943033_CR20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00320890","volume":"53","author":"E. R. Grumayer","year":"1986","unstructured":"Grumayer, E. R., Schmidmeier, W., Panzer, S., Gadner, H. Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukaemia. BLUT 1986: 53, 309\u2013314.","journal-title":"BLUT"},{"key":"BF02943033_CR21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/1097-0142(19800315)45:6<1284::AID-CNCR2820450604>3.0.CO;2-Q","volume":"45","author":"G. Rivera","year":"1980","unstructured":"Rivera, G., Aur, R. J., Dahl, G. V., Pratt, C., B., Wood, A., Avery, T. L. Combined VM-26 and Cytosine Arabinoside in treatment of refractory childhood lymphocytic leukaemia. Cancer 1980: 45, 1284\u20131288.","journal-title":"Cancer"},{"key":"BF02943033_CR22","unstructured":"Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation: Allogenic bone marrow transplantation for leukaemia in Europe. Lancet 1988: i, 1379\u20131382."},{"key":"BF02943033_CR23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198708203170801","volume":"317","author":"J. H. Kersey","year":"1987","unstructured":"Kersey, J. H., Weisdorf, D., Nesbit, M. E., LeBien, T. W., Woods, W. G., McGlave, P. B., Kim, T., Vallera, D. A., Goldman, A. I., Bostrom, B., Hurd, D., Ramsay, N. K., Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukaemia. N. Engl. J. Med. 1987: 317, 461\u2013467.","journal-title":"N. Engl. J. Med."},{"key":"BF02943033_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V67.2.415.415","volume":"67","author":"C. D. Bloomfield","year":"1986","unstructured":"Bloomfield, C. D., Goldman, A. I., Alimena, G., Berger, R., Borgstrom, G. H., Brandt, L., Catovsky, D., De La Chapelle, A., Dewald, G. W., Garson, O. M., Garwicz, S., Golomb, H. M., Hossfeld, D. K., Lawler, S. D., Mitelman, F., Nilsson, P., Pierre, R. V., Philip, P., Prigogina, E., Rowley, J. D., Sakura, M., Sandberg, A. A., Seeker Walker, L. M., Tricot, G., Van Den Berghe, H., Van Orshoven, A., Vuopio, P., Whang-Peng, J. Chromosomal abnormalities identify high risk and low risk patients with acute lymphoblastic leukaemia. Blood 1986: 67, 415\u2013420.","journal-title":"Blood"},{"key":"BF02943033_CR25","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/blood.V70.6.1933.1933","volume":"70","author":"A. Tawa","year":"1987","unstructured":"Tawa, A., Benedict, S.H., Hara, J., Hozumi, N., Gelfand, E. W. Rearrangement of T cell receptor \u03b1-chain gene in childhood acute lymphoblastic leukaemia. Blood 1987: 70, 1933\u20131939.","journal-title":"Blood"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02943033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02943033\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02943033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T04:01:22Z","timestamp":1588910482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02943033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["BF02943033"],"URL":"https:\/\/doi.org\/10.1007\/bf02943033","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,5]]}}}